(Q43278790)

English

A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia

scientific article published on 10 September 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 November 2017

A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia (English)

1 reference

Europe PubMed Central

18 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Lauren Silverman

object named as

L Silverman

4

0 references

2

object named as

P Gaynon

1 reference

Europe PubMed Central

18 November 2017

author name string

N Hijiya

1

1 reference

Europe PubMed Central

18 November 2017

E Barry

3

1 reference

Europe PubMed Central

18 November 2017

B Thomson

5

1 reference

Europe PubMed Central

18 November 2017

R Chu

6

1 reference

Europe PubMed Central

18 November 2017

T Cooper

7

1 reference

Europe PubMed Central

18 November 2017

R Kadota

8

1 reference

Europe PubMed Central

18 November 2017

M Rytting

9

1 reference

Europe PubMed Central

18 November 2017

P Steinherz

10

1 reference

Europe PubMed Central

18 November 2017

V Shen

11

1 reference

Europe PubMed Central

18 November 2017

S Jeha

12

1 reference

Europe PubMed Central

18 November 2017

R Abichandani

13

1 reference

Europe PubMed Central

18 November 2017

W L Carroll

14

1 reference

Europe PubMed Central

18 November 2017

publication date

10 September 2009

1 reference

Europe PubMed Central

18 November 2017

1 reference

Europe PubMed Central

18 November 2017

23

1 reference

Europe PubMed Central

18 November 2017

12

1 reference

Europe PubMed Central

18 November 2017

2259-2264

1 reference

Europe PubMed Central

18 November 2017

https://scigraph.springernature.com/pub.10.1038/leu.2009.185

0 references

SEER update of incidence and trends in pediatric malignancies: acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.185

21 January 2018

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.185

21 January 2018

Childhood acute lymphoblastic leukaemia and relapse

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.185

21 January 2018

Synthesis and biological activity of 2'-fluoro-2-halo derivatives of 9-.beta.-D-arabinofuranosyladenine

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.185

21 January 2018

Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.185

21 January 2018

Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.185

21 January 2018

Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.185

21 January 2018

Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected]

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.185

21 January 2018

Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.185

21 January 2018

Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial. MRC Childhood Leukaemia Working Party

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.185

21 January 2018

Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.185

7 January 2021

based on heuristic

inferred from DOI database lookup

Neurotoxicity of purine analogs: a review

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.185

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2009.185

1 reference

Europe PubMed Central

18 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

18 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43278790&oldid=1985520139"